Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice M Seddon

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Radiology|January 21, 2011
Uterine sarcomas--recent progress and future challengesBeatrice M Seddon, Reena Davda
Paediatric Drugs|March 19, 2008
Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcomaBeatrice M Seddon, Jeremy S Whelan
Cancer|February 19, 2008
Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patientsVasilios Karavasilis, Beatrice M Seddon, Susan Ashley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopyBeatrice M Seddon, Ross J Maxwell, Davina J Honess, et al.
BMC Cancer|May 8, 2016
Follow-up practices for high-grade extremity OsteosarcomaChristian Rothermundt, Beatrice M Seddon, Palma Dileo, et al.
British Journal of Cancer|May 11, 2024
UK guidelines for the management of soft tissue sarcomasAndrew J Hayes, Ioanna F Nixon, Dirk C Strauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancyBeatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Clinical outcome in patients with peripherally-sited atypical lipomatous tumours and dedifferentiated liposarcomaSangeetha N Kalimuthu, Charles Tilley, Georgina Forbes, et al.
British Journal of Cancer|September 8, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strataPenella J Woll, Piers Gaunt, Charlotte Gaskell, et al.
The British Journal of Radiology|April 4, 2019
Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomasSebastien Tran, Emsad Puric, Marc Walser, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Radiology|January 21, 2011
Uterine sarcomas--recent progress and future challengesBeatrice M Seddon, Reena Davda
Paediatric Drugs|March 19, 2008
Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcomaBeatrice M Seddon, Jeremy S Whelan
Cancer|February 19, 2008
Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patientsVasilios Karavasilis, Beatrice M Seddon, Susan Ashley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopyBeatrice M Seddon, Ross J Maxwell, Davina J Honess, et al.
BMC Cancer|May 8, 2016
Follow-up practices for high-grade extremity OsteosarcomaChristian Rothermundt, Beatrice M Seddon, Palma Dileo, et al.
British Journal of Cancer|May 11, 2024
UK guidelines for the management of soft tissue sarcomasAndrew J Hayes, Ioanna F Nixon, Dirk C Strauss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancyBeatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Clinical outcome in patients with peripherally-sited atypical lipomatous tumours and dedifferentiated liposarcomaSangeetha N Kalimuthu, Charles Tilley, Georgina Forbes, et al.
British Journal of Cancer|September 8, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strataPenella J Woll, Piers Gaunt, Charlotte Gaskell, et al.
The British Journal of Radiology|April 4, 2019
Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomasSebastien Tran, Emsad Puric, Marc Walser, et al.
Pageof 2